A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Recruiting · NCT07093528 · Observational (researchers observe without assigning treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →Interventions studied
Cardiovascular Magnetic Resonance (CMR)
What this trial is about
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥18
- Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Exclusion criteria
- Metal implants that are not suitable for MRI
- Inability or unwillingness of individual to give written informed consent.
Where it is running
1 location listed across 1 US state.
- Mayo Clinic - Rochester, Minnesota, United States